Morgan Stanley initiated coverage of Tenet Healthcare (THC) with an Overweight rating and $165 price target The firm says the company’s ...

Stock analysts at Morgan Stanley started coverage on shares of Tenet Healthcare (NYSE:THC – Get Free Report) in a research ...

Analysts have recently evaluated Tenet Healthcare and provided 12-month price targets. The average target is $172.6, accompanied by a high estimate of $185.00 and a low estimate of $161.00. A 8.8% ...

Fintel reports that on March 26, 2025, Morgan Stanley initiated coverage of Tenet Healthcare (NYSE:THC) with a Overweight ...

Tenet Healthcare Corporation’s THC shares have surged 26.9% in the past year against the industry’s 2.2% decline. It has also outperformed the broader Zacks Medical sector’s 11% decline and ...

Tenet Healthcare (THC) ended the recent trading session at $133.04, demonstrating a +1.73% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily loss ...

Tenet Healthcare received an upgrade to its Relative Strength (RS) Rating, from 67 to 72. Please watch the video at Investors ...

Tuesday said that it has incorporated a new wholly-owned subsidiary to conduct business in the U.S. ahead of the company's planned expansion of the Business Hub to that market in the second quarter of ...